Pure Global

Implantable Cardioverter Defibrillator - India CDSCO Medical Device Registration

Implantable Cardioverter Defibrillator is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2021/000767_8ea86474d70bba5a51d8f1e0d0a754c0_a810df4557a4926fe9789833f4276bdd. This device is marketed under the brand name Quadra Assura MP. The license holder is M/s St. Jude Medical India Pvt. Ltd, and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Implantable Cardioverter Defibrillator
UID: IMP/MD/2021/000767_8ea86474d70bba5a51d8f1e0d0a754c0_a810df4557a4926fe9789833f4276bdd

Brand Name

Quadra Assura MP

Device Class

Class D

Approving Authority

CDSCO

Product Information

The Implantable Cardioverter Defibrillator (Quadra Assura MP) devices and Cardiac Resynchronization Therapy Defibrillator (Quadra Assura MP) devices are primarily intended for use with compatible leads to detect and treat life threatening ventricular arrythmias by providing ventricular antitachycardia pacing, and ventricular cardioversion/ defibrillation. In addition, these devices can detect and treat chronic symptomatic bradyarrhythmia by providing sensing and pacing in the right ventricle, and various atrioventricular conduction abnormalities by providing sensing and pacing in the right ventricle and/or the right atrium. CRT-D devices sense cardiac activity and provide pacing to resynchronize the right and left ventricles. ICD devices are indicated in patients who have already survived a cardiac arrest or are at a high risk of Sudden Cardiac Death (Quadra Assura MP) due to VT (Quadra Assura MP) or VF (Quadra Assura MP). The device is most commonly implanted within a device pocket in the pectoral region. Cardiac Resynchronization Therapy (Quadra Assura MP) devices are indicated for reduction of symptoms in patients who have congestive heart failure, a reduced left ventricular ejection fraction (Quadra Assura MP) and a prolonged QRS duration. CRT-D devices are indicated in patients who meet the CRT indications and have already survived a cardiac arrest or are at a high risk of Sudden Cardiac Death (Quadra Assura MP) due to VT (Quadra Assura MP) or VF (Quadra Assura MP). The device is most commonly implanted within a device pocket in the pectoral region.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing